Girl, 2, to be saved by bone marrow transplant from 10-month-old sibling
A two-year-old girl from Essex with a rare illness will undergo a life-saving bone marrow transplant after doctors discovered her baby brother was a match. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2014 Category: Consumer Health News Source Type: news

Virginia Boy Responding To Chimerix Anti-Adenovirus Drug; Celebrates 8th Birthday
The family of Josh Hardy reports their son is responding well to an experimental antiviral drug provided by Chimerix last month. The boy developed an adenovirus infection following a bone marrow transplant for a type of kidney cancer he's been fighting since a nine-month-old infant. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 3, 2014 Category: Pharmaceuticals Authors: David Kroll Source Type: news

Kenya: Kisumu Mum Needs Sh21 Million to Treat Leukaemia
[The Star]A single mother of three in Kisumu has asked the government and wellwishers to help her raise Sh21 million for a bone marrow transplant. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 28, 2014 Category: African Health Source Type: news

HIV 's efficiency makes it a formidable foe
Although antiretroviral drug therapy suppresses the virus, it cannot get rid of it or end the epidemicAntiretroviral drugs have been an astounding success story, reprieving people with HIV from the brink of death and allowing them to live a full and healthy life. But although the roll-out across the world has saved lives and removed the distressing pictures of wasted Aids victims from our TV screens, experts know the drugs will not end the epidemic. The hunt is on for a cure, but it is proving tough.Antiretroviral drug therapy suppresses the virus to such low levels that people with HIV are no longer infectious, but it can...
Source: Guardian Unlimited Science - March 6, 2014 Category: Science Authors: Sarah Boseley Tags: The Guardian United States World news Health Medical research UK news Aids and HIV Science Society Source Type: news

HIV gene therapy using GM cells hailed a success after trial
Radical treatment helps patients' defences against virus by replacing immune cells with genetically modified versionsA radical gene therapy to combat HIV using genetically modified cells that are resistant to the virus has been declared a success by scientists following the first clinical trial.The treatment, which has never been tested on humans before, raised patients' defences against HIV by replacing some of their natural immune cells with GM versions.Tests on people enrolled in the trial found that the disease-resistant cells multiplied in their bodies.Half of patients were taken off their usual drugs for three months...
Source: Guardian Unlimited Science - March 5, 2014 Category: Science Authors: Ian Sample Tags: The Guardian United States Genetics News Medical research Aids and HIV Science Source Type: news

HIV gene therapy using GM cells hailed a success after trial
Radical treatment helps patients' defences against virus by replacing immune cells with genetically modified versionsA radical gene therapy to combat HIV using genetically modified cells that are resistant to the virus has been declared a success by scientists following the first clinical trial.The treatment, which has never been tested on humans before, raised patients' defences against HIV by replacing some of their natural immune cells with GM versions.Tests on people enrolled in the trial found that the disease-resistant cells multiplied in their bodies.Half of patients were taken off their usual drugs for three months...
Source: Guardian Unlimited Science - March 5, 2014 Category: Science Authors: Ian Sample Tags: Medical research Aids and HIV Genetics United States The Guardian News Science Source Type: news

Global Bone Marrow Transplantation Analysis and Market Growth, Trend,...
MarketResearchReports.Biz announces addition of new report “Bone Marrow Transplantation - Pipeline Review, H1 2014” to its database. Visit:...(PRWeb February 18, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11592756.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 18, 2014 Category: Pharmaceuticals Source Type: news

Global Bone Marrow Transplantation Analysis and Market Growth, Trend,...
MarketResearchReports.Biz announces addition of new report “AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014” to its database. Visit:...(PRWeb February 18, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11592769.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 18, 2014 Category: Pharmaceuticals Source Type: news

New treatment proposed to prevent intestinal inflammation in cancer patients
(The Hebrew University of Jerusalem) Experimental work pointing to a therapy for alleviating mucositis -- a common, severe side effect of chemotherapy and irradiation of cancer patients or patients prepared for bone marrow transplantation - has been achieved by an international team of researchers from the US and Israel headed by scientists at the Hebrew University of Jerusalem. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 18, 2014 Category: Cancer & Oncology Source Type: news

Kenya: Girl Needs Sh5 Million for Transplant
[The Star]A five-years-old nursery schoolgirl, who has undergone 20 blood transfusions, requires Sh5 million to undergo a bone marrow transplant in India. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 14, 2014 Category: African Health Source Type: news

Tia Pugh needs a bone marrow transplant as she battles TWO incredibly rare diseases
Tia Pugh, from Worcester, needs a life-saving bone marrow transplant because she has a rare form of immune deficiency as well as a tuberculosis-like illness. (Source: the Mail online | Health)
Source: the Mail online | Health - February 6, 2014 Category: Consumer Health News Source Type: news

Donated human eye cells could help restore vision
Conclusion This study has found that rod cells developed from hMSCs in the laboratory could restore rod cell function in rats that had been genetically engineered so that their rod cells died. This offers the potential for treatment that could restore the vision of people with visual impairment of the broad perception of light and dark, the size and shape of objects, and movement. Even though restoring some rod cell function would not provide detailed vision, it could help with carrying out normal activities of daily life, such as moving around and getting food and drink. As the researchers say, using rod cells derived f...
Source: NHS News Feed - February 3, 2014 Category: Consumer Health News Tags: Genetics/stem cells Medical practice Source Type: news

Widely-touted HIV cure turns out to be false; patients once again test HIV positive
It was big news back in 2013 -- science unveils an alleged cure for AIDS after two men from Boston test negative for HIV following successful bone marrow transplants, read the glowing headlines. Except this apparently was not the case. New reports now indicate that both... (Source: NaturalNews.com)
Source: NaturalNews.com - January 16, 2014 Category: Consumer Health News Source Type: news

John Goldman obituary
Pioneer in bone-marrow transplantation for chronic myeloid leukaemia, which has enabled thousands of patients to live normal livesWhen John Goldman began his career in the 1960s, the diagnosis of chronic myeloid leukaemia (CML) carried a grim prognosis and a life expectancy of only three to five years. Today, thousands of patients have been cured or enjoy relatively normal lives because of his seminal contributions. John, who has died aged 75, pioneered bone-marrow transplantation for CML and later championed the drug imatinib that transformed the treatment of the disease.For 23 years from 1988 he was medical director of t...
Source: Guardian Unlimited Science - January 13, 2014 Category: Science Authors: George Q Daley Tags: theguardian.com Obituaries Medical research Cancer Science Source Type: news

What Relapse of Men "Functionally Cured" of HIV Taught Us
"Disappointment" was the word most often used to describe the report that two Boston men, proclaimed "functionally cure" of HIV in 2012, relapsed after only a year. It was hoped that the bone marrow transplant they underwent to treat  lymphoma (a type of cancer that affects certain blood cells) would effectively clear their bodies of HIV in the same way that it appears to have done with Timothy Ray Brown, the Berlin-based American who underwent a stem cell transplant in 2009 and remains "virus-free" after four years....Read Full Post (Source: About AIDS / HIV)
Source: About AIDS / HIV - January 6, 2014 Category: Consumer Health News Source Type: news

Make a resolution to become a bone marrow donor, urge parents of brave leukaemia girl, 7
Seven-year-old Rhiane Francois is undergoing chemotherapy to treat leukaemia - but if the drugs are not effective she will need a bone marrow transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - January 1, 2014 Category: Consumer Health News Source Type: news

Boy, 4, kept in sterile 'bubble' to protect him from germs hopes to finally spend Christmas with family he's not seen for four months
Samuel Freeman, from Leicestershire, has a rare condition which means he has no immunity to any germs. He is waiting for a bone marrow transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - December 23, 2013 Category: Consumer Health News Source Type: news

HIV returns in 2 patients
HIV has returned in two patients who doctors hoped had been cured of the virus following bone marrow transplants, the Boston researcher who treated them said Saturday. (Source: CNN.com - Health)
Source: CNN.com - Health - December 9, 2013 Category: Consumer Health News Source Type: news

HIV Returns in Two Bone-Marrow Transplant Patients in Remission (FREE)
By Kelly Young HIV has reappeared in two patients in whom the virus had dropped to undetectable levels after bone-marrow transplants, the Boston Globe reports.The patients had undergone the transplants for Hodgkin's … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 9, 2013 Category: Primary Care Source Type: news

Half-Matched Tx an Option for Older Patients (CME/CE)
NEW ORLEANS (MedPage Today) -- Older patients with advanced or poor-risk hematologic malignancies, including multiple myeloma, seemed to have survival outcomes similar to that of younger patients following nonmyeloablative haploidentical bone marrow transplantation, a retrospective case series showed. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - December 7, 2013 Category: Consumer Health News Source Type: news

HIV returns in 2 after bone marrow transplant
HIV has returned in two patients who doctors hoped had been cured of the virus following bone marrow transplants, the Boston researcher who treated them said Saturday. The HIV virus became undetectable in both patients approximately eight months afte... (Source: WDSU.com - Health)
Source: WDSU.com - Health - December 7, 2013 Category: Consumer Health News Source Type: news

HIV returns in 2 patients after bone marrow transplant
HIV has returned in two patients who doctors hoped had been cured of the virus following bone marrow transplants, the Boston researcher who treated them said Saturday. (Source: CNN.com - Health)
Source: CNN.com - Health - December 7, 2013 Category: Consumer Health News Source Type: news

Hoped-For AIDS Cures Fail In 2 Boston Patients
The only person known to have been cured of AIDS got a bone marrow transplant, so when two AIDS patients in Boston appeared to be free of the virus after transplants, scientists hoped they were cured, too. But the HIV virus has returned in both.» E-Mail This     » Add to Del.icio.us (Source: NPR Health and Science)
Source: NPR Health and Science - December 6, 2013 Category: Consumer Health News Source Type: news

New drug cuts risk of deadly transplant side effect in half
(University of Michigan Health System) A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive Cancer Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 2, 2013 Category: Global & Universal Source Type: news

Toddler Gaurav Bains' bone marrow transplant hope as donor is found
The campaign to find a bone marrow donor for Gaurav Bains (pictured with his mother, Gurprit), two, from the West Midlands, inspired a 10-fold increase in the number of Asian donors registering. (Source: the Mail online | Health)
Source: the Mail online | Health - November 21, 2013 Category: Consumer Health News Source Type: news

Common chemo drug thwarts graft rejection in bone marrow transplants
Results of a Johns Hopkins study may explain why a chemotherapy drug called cyclophosphamide prevents graft-versus-host (GVHD) disease in people who receive bone marrow transplants. The experiments point to an immune system cell that evades the toxic effects of cyclophosphamide and protects patients from a lethal form of GVHD.The findings, published online in Science Translational Medicine, could pave the way for improvements in preventing GVHD and rejection of transplanted bone marrow and new therapies to prevent or treat a relapse of the underlying cancer after a transplant. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 15, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Drug offers promising approach to improve outcome for children with high-risk leukemia
(St. Jude Children's Research Hospital) Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2013 Category: Global & Universal Source Type: news

Drug offers promising approach to improve outcome for children with high-risk leukemia
St. Jude Children’s Research Hospital leads study showing that a drug withdrawn from the market in 2010 may enhance the effectiveness of bone marrow transplants for select pediatric leukemia patients. (Dr. Jeffrey Rubnitz) (Source: St. Jude Children's Research Hospital)
Source: St. Jude Children's Research Hospital - November 15, 2013 Category: Pediatrics Source Type: news

Peanut Allergy Cured After Bone Marrow TransplantPeanut Allergy Cured After Bone Marrow Transplant
Genetic modifications during the early stages of immune cell development in bone marrow may play a large role in allergy. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2013 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Mystery Explained: How a Common Chemo Drug Thwarts Graft Rejection in Bone Marrow Transplants - 11/14/13
Results of a Johns Hopkins study may explain why a chemotherapy drug called cyclophosphamide prevents graft-versus-host (GVHD) disease in people who receive bone marrow transplants. (Source: Johns Hopkins Medicine News)
Source: Johns Hopkins Medicine News - November 14, 2013 Category: Research Source Type: news

Peanut Allergy, Bone Marrow Link Offers Clues
BALTIMORE (MedPage Today) -- An 8-year-old boy was cured of his peanut allergy following a bone marrow transplant for acute lymphocytic Leukemia (ALL), a researcher reported here. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - November 13, 2013 Category: Consumer Health News Source Type: news

Life-saving transplant results in end to peanut allergy
Not only can bone marrow transplants be life-saving for children with acute lymphocytic leukemia, they may also cure peanut allergies. According to research presented during the American College of Allergy, Asthma and Immunology's (ACAAI) Annual Scientific Meeting, a 10-year-old boy no longer had a peanut allergy after undergoing a bone marrow transplant. "It has been reported that bone marrow and liver transplants can transfer peanut allergy from donor to recipient," said allergist Yong Luo, MD, Ph.D., ACAAI member and lead study author... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2013 Category: Consumer Health News Tags: Allergy Source Type: news

Did Bone Marrow Transplant Cure Peanut Allergy?
Title: Did Bone Marrow Transplant Cure Peanut Allergy?Category: Health NewsCreated: 11/8/2013 12:35:00 PMLast Editorial Review: 11/11/2013 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - November 11, 2013 Category: Allergy & Immunology Source Type: news

Did Bone Marrow Transplant Cure Peanut Allergy?
Unusual case report details how 10-year-old boy was treated for leukemia and lost sensitivity to peanuts (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 9, 2013 Category: Cancer & Oncology Source Type: news

Did Bone Marrow Transplant Cure Peanut Allergy?
Unusual case report details how 10-year-old boy was treated for leukemia and lost sensitivity to peanuts (Source: WebMD Health)
Source: WebMD Health - November 8, 2013 Category: Consumer Health News Source Type: news

Did Bone Marrow Transplant Cure Peanut Allergy?
Unusual case report details how 10-year-old boy was treated for leukemia and lost sensitivity to peanuts (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 8, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Allergy, News, Source Type: news

The great disappearing act: Bone marrow receiver cured of allergy
(American College of Allergy, Asthma, and Immunology) Not only can bone marrow transplants be life-saving for children with acute lymphocytic leukemia, they may also cure peanut allergies. According to research presented during the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting, a 10-year-old boy no longer had a peanut allergy after undergoing a bone marrow transplant. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2013 Category: Global & Universal Source Type: news

Potential new targets for blocking graft-vs.-host disease could impact bone marrow transplants
Researchers from the University of Michigan Comprehensive Cancer Center have identified new proteins that control the function of critical immune cell subsets called T-cells, which are responsible for a serious and often deadly side effect of lifesaving bone marrow transplants. These new proteins have not previously been associated with T-cell responses. T-cells help fight infections but also can trigger autoimmune diseases or graft vs. host disease, a side effect of bone marrow transplant in which the new donor cells begin attacking other cells in the patient's body... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 5, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Newly identified proteins make promising targets for blocking graft-vs.-host disease
(University of Michigan Health System) Researchers from the University of Michigan Comprehensive Cancer Center have identified new proteins that control the function of critical immune cell subsets called T-cells, which are responsible for a serious and often deadly side effect of lifesaving bone marrow transplants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2013 Category: Global & Universal Source Type: news

William S. Dalton, Ph.D., MD
CEO, M2Gen Dr. William Dalton is CEO of M2Gen, a Moffitt Cancer Center biotechnology company.  Additionally, he is founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s brand of personalized medicine, Total Cancer Care®. Dr. Dalton served as president and CEO of Moffitt from 2002 to 2012 and was instrumental in helping the Cancer Center achieve tremendous growth and innovation.  He facilitated the launch of M2Gen and the development of Moffitt Total Cancer Care®. Dr. Dalton received his Ph.D. and medical degree from Indiana University School ...
Source: PHRMA - October 25, 2013 Category: Pharmaceuticals Authors: Leah Source Type: news

Stem Cell Transplants May Harm Recipient's Sex Life
Doctors and patients need to talk more about this potential problem, researchers say Source: HealthDay Related MedlinePlus Pages: Bone Marrow Transplantation, Sexual Health, Stem Cells (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 24, 2013 Category: Consumer Health News Source Type: news

Study ties bone marrow transplant to negative sexual side effects
(American Society of Hematology) New research ties preparative procedures and complications associated with blood or bone marrow transplantation (stem cell transplantation, SCT) with diminished sexual health in both men and women who have undergone the lifesaving procedure. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 24, 2013 Category: Global & Universal Source Type: news

Child bone-marrow transplant 'first'
Three UK children at London's Great Ormond Street Hospital become the first patients to try out a pioneering bone marrow transplant technique. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 22, 2013 Category: Consumer Health News Source Type: news

Immune marker predicts transplant success and improves selection of bone marrow donors
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the Journal of Clinical Oncology. The research builds on an earlier St. Jude discovery that specialized immune cells called natural killer (NK) cells dispatched cancer cells more efficiently when the NK cells carried a particular version of a KIR protein on their surface... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 19, 2013 Category: Consumer Health News Tags: Transplants / Organ Donations Source Type: news